Production and Quality Control of Actinium-225 Radiopharmaceuticals

This publication includes existing experiences, lessons learned, challenges and future developments in the production of Ac-225 radiopharmaceuticals for Targeted Alpha Therapy (TAT). This publication will be utilized by all involved professionals in the Targeted Alpha Therapy field, specifying ideal production, formulation, quality control and regulatory aspects of various Ac-225 radiopharmaceuticals. The intended audience also includes radiochemists, radiopharmacists, and medical physicists.